
### [MONDO:0018041](http://purl.obolibrary.org/obo/MONDO_0018041)
**Label:** other immunodeficiency syndrome with predominantly antibody defects

**Subclasses:** [MONDO:0014487](http://purl.obolibrary.org/obo/MONDO_0014487) (congenital sideroblastic anemia-B-cell immunodeficiency-periodic fever-developmental delay syndrome), [MONDO:0012859](http://purl.obolibrary.org/obo/MONDO_0012859) (autosomal recessive osteopetrosis 7), [MONDO:0009620](http://purl.obolibrary.org/obo/MONDO_0009620) (Say-Barber-Miller syndrome), [MONDO:0014722](http://purl.obolibrary.org/obo/MONDO_0014722) (Roifman syndrome), [MONDO:0017407](http://purl.obolibrary.org/obo/MONDO_0017407) (deficiency in anterior pituitary function-variable immunodeficiency syndrome), 

**Mapped go classes:** [GO:0043507](http://purl.obolibrary.org/obo/GO_0043507) (positive regulation of JUN kinase activity), [GO:0060086](http://purl.obolibrary.org/obo/GO_0060086) (circadian temperature homeostasis), [GO:0005031](http://purl.obolibrary.org/obo/GO_0005031) (tumor necrosis factor-activated receptor activity), [GO:0051091](http://purl.obolibrary.org/obo/GO_0051091) (positive regulation of DNA binding transcription factor activity), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0001503](http://purl.obolibrary.org/obo/GO_0001503) (ossification), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0071812](http://purl.obolibrary.org/obo/GO_0071812) (positive regulation of fever generation by positive regulation of prostaglandin secretion), [GO:0071848](http://purl.obolibrary.org/obo/GO_0071848) (positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling), [GO:0008033](http://purl.obolibrary.org/obo/GO_0008033) (tRNA processing), [GO:1990180](http://purl.obolibrary.org/obo/GO_1990180) (mitochondrial tRNA 3'-end processing), [GO:0002250](http://purl.obolibrary.org/obo/GO_0002250) (adaptive immune response), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0001680](http://purl.obolibrary.org/obo/GO_0001680) (tRNA 3'-terminal CCA addition), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0033209](http://purl.obolibrary.org/obo/GO_0033209) (tumor necrosis factor-mediated signaling pathway), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0070555](http://purl.obolibrary.org/obo/GO_0070555) (response to interleukin-1), [GO:0071847](http://purl.obolibrary.org/obo/GO_0071847) (TNFSF11-mediated signaling pathway), [GO:0019955](http://purl.obolibrary.org/obo/GO_0019955) (cytokine binding), [GO:0034612](http://purl.obolibrary.org/obo/GO_0034612) (response to tumor necrosis factor), [GO:0034097](http://purl.obolibrary.org/obo/GO_0034097) (response to cytokine), [GO:0007275](http://purl.obolibrary.org/obo/GO_0007275) (multicellular organism development), [GO:0009897](http://purl.obolibrary.org/obo/GO_0009897) (external side of plasma membrane), [GO:0097190](http://purl.obolibrary.org/obo/GO_0097190) (apoptotic signaling pathway), [GO:0048535](http://purl.obolibrary.org/obo/GO_0048535) (lymph node development), [GO:0007632](http://purl.obolibrary.org/obo/GO_0007632) (visual behavior), [GO:0000166](http://purl.obolibrary.org/obo/GO_0000166) (nucleotide binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0060749](http://purl.obolibrary.org/obo/GO_0060749) (mammary gland alveolus development), [GO:0001966](http://purl.obolibrary.org/obo/GO_0001966) (thigmotaxis), [GO:0016779](http://purl.obolibrary.org/obo/GO_0016779) (nucleotidyltransferase activity), [GO:0009022](http://purl.obolibrary.org/obo/GO_0009022) (tRNA nucleotidyltransferase activity), [GO:0052928](http://purl.obolibrary.org/obo/GO_0052928) (CTP:3'-cytidine-tRNA cytidylyltransferase activity), [GO:0052929](http://purl.obolibrary.org/obo/GO_0052929) (ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity), [GO:0006396](http://purl.obolibrary.org/obo/GO_0006396) (RNA processing), [GO:0000049](http://purl.obolibrary.org/obo/GO_0000049) (tRNA binding), [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface), [GO:0030316](http://purl.obolibrary.org/obo/GO_0030316) (osteoclast differentiation), [GO:0001654](http://purl.obolibrary.org/obo/GO_0001654) (eye development), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0052927](http://purl.obolibrary.org/obo/GO_0052927) (CTP:tRNA cytidylyltransferase activity), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), 

**Class expressions from DL-Learner:**

- [GO:0042780](http://purl.obolibrary.org/obo/GO_0042780) (tRNA 3'-end processing) 56.67%
- [GO:1990817](http://purl.obolibrary.org/obo/GO_1990817) (RNA adenylyltransferase activity) 53.33%
- [GO:1990180](http://purl.obolibrary.org/obo/GO_1990180) (mitochondrial tRNA 3'-end processing) 53.33%
- [GO:0060086](http://purl.obolibrary.org/obo/GO_0060086) (circadian temperature homeostasis) 53.33%
- [GO:0052929](http://purl.obolibrary.org/obo/GO_0052929) (ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity) 53.33%
- [GO:0052928](http://purl.obolibrary.org/obo/GO_0052928) (CTP:3'-cytidine-tRNA cytidylyltransferase activity) 53.33%
- [GO:0052927](http://purl.obolibrary.org/obo/GO_0052927) (CTP:tRNA cytidylyltransferase activity) 53.33%
- [GO:0009986](http://purl.obolibrary.org/obo/GO_0009986) (cell surface) 53.33%
- [GO:0009022](http://purl.obolibrary.org/obo/GO_0009022) (tRNA nucleotidyltransferase activity) 53.33%
- [GO:0005622](http://purl.obolibrary.org/obo/GO_0005622) (intracellular) 53.33%
- [GO:0004810](http://purl.obolibrary.org/obo/GO_0004810) (tRNA adenylyltransferase activity) 53.33%
- [GO:0004652](http://purl.obolibrary.org/obo/GO_0004652) (polynucleotide adenylyltransferase activity) 53.33%
- [GO:0001966](http://purl.obolibrary.org/obo/GO_0001966) (thigmotaxis) 53.33%
- [GO:0001680](http://purl.obolibrary.org/obo/GO_0001680) (tRNA 3'-terminal CCA addition) 53.33%
- [GO:0043628](http://purl.obolibrary.org/obo/GO_0043628) (ncRNA 3'-end processing) and [GO:0090646](http://purl.obolibrary.org/obo/GO_0090646) (mitochondrial tRNA processing) 53.33%


